The supplier of drugs to nursing homes said that John Figueroa has resigned after 18 months as chief executive. The shares fell the most in eight months. John Workman, president and chief financial officer, will be interim CEO. Nitin Sahney, an executive vice president, will be promoted to chief operating officer.